Beacon Trust’s iShares Biotechnology ETF IBB Stock Holding History

Beacon Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$220K	Sell	2,217 -219	-9%	-$21K	0.03%	171
2016 Q4	$215K	Buy	2,436 +78	+3%	+$7.1K	0.04%	169
2016 Q3	$228K	Sell	2,358 -51	-2%	-$4.85K	0.04%	162
2016 Q2	$207K	Buy	+2,409	New	+$216K	0.04%	171
2015 Q2	–	Sell	-3,327	Closed	-$381K	–	206
2015 Q1	$381K	Sell	3,327 -3,780	-53%	-$417K	0.06%	153
2014 Q4	$719K	Sell	7,107 -34,554	-83%	-$3.36M	0.11%	119
2014 Q3	$3.8M	Sell	41,661 -36,141	-46%	-$3.17M	0.63%	59
2014 Q2	$6.67M	Sell	77,802 -1,674	-2%	-$132K	1.1%	34
2014 Q1	$6.26M	Sell	79,476 -60	-0.1%	-$5K	1.07%	35
2013 Q4	$6.02M	Sell	79,536 -4,740	-6%	-$336K	1.04%	35
2013 Q3	$5.89M	Buy	+84,276	New	+$5.52M	1.09%	31

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Beacon Trust's IBB Position: Q1 2017 in Review

Beacon Trust reduced its iShares Biotechnology ETF (IBB) stake by 9% in Q1 2017, selling an estimated $21K and leaving 2,217 shares worth $220K. The position accounts for 0.03% of the portfolio, ranked #171.

Beacon Trust first reported a position in IBB in Q3 2013 and has held it in 11 quarters since. The position peaked at $6.67M in Q2 2014. 520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

Beacon Trust held 2,217 shares of iShares Biotechnology ETF worth $220K as of Q1 2017.
Beacon Trust sold 219 iShares Biotechnology ETF shares in Q1 2017, an estimated $21K.
iShares Biotechnology ETF made up 0.03% of Beacon Trust's portfolio in Q1 2017, its #171 holding.
Beacon Trust first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 11 quarters since.
Beacon Trust's iShares Biotechnology ETF position peaked at $6.67M in Q2 2014.
520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.